Daryl has over twenty-eight years experience in developing and using glycoprofiling technology in medicine and biotechnology. He gained his doctorate in structural analysis of biological oligosaccharides at the Glycobiology Institute, University of Oxford in the 1980s, was a consultant on biopharmaceutical glycoprofiling to Monsanto and G.D. Searle and helped spin out Oxford GlycoSciences (OGS) from the University. OGS was the second high technology company to spin out of Oxford University and specialised in glycoanalysis products and services for biopharma. Daryl joined OGS in 1993 as Process Development Manager and then as the Head of Analytical Services. He set up Ludger in 1999.